Global Brain Tumor Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4883072
- 89 Pages
- March 2022
- Pharmaceuticals
The United States Brain Tumor Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Brain Tumor Drugs market, reaching US$ million by the year 2028. As for the Europe Brain Tumor Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Brain Tumor Drugs players cover Pfizer Inc., Bristol-Myers Squibb, AstraZeneca, and Merck and Co. Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Brain Tumor Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Temozolomide
Carmustine
Cisplatin
Bevacizumab
Geftinib
Erlotinib
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Online
Offline
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer Inc.
Bristol-Myers Squibb
AstraZeneca
Merck and Co. Inc.
Johnson and Johnson
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brain Tumor Drugs Market Size 2017-2028
2.1.2 Brain Tumor Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Brain Tumor Drugs Segment by Type
2.2.1 Temozolomide
2.2.2 Carmustine
2.2.3 Cisplatin
2.2.4 Bevacizumab
2.2.5 Geftinib
2.2.6 Erlotinib
2.3 Brain Tumor Drugs Market Size by Type
2.3.1 Brain Tumor Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Brain Tumor Drugs Market Size Market Share by Type (2017-2022)
2.4 Brain Tumor Drugs Segment by Application
2.4.1 Online
2.4.2 Offline
2.5 Brain Tumor Drugs Market Size by Application
2.5.1 Brain Tumor Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Brain Tumor Drugs Market Size Market Share by Application (2017-2022)
3 Brain Tumor Drugs Market Size by Player
3.1 Brain Tumor Drugs Market Size Market Share by Players
3.1.1 Global Brain Tumor Drugs Revenue by Players (2020-2022)
3.1.2 Global Brain Tumor Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Brain Tumor Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Brain Tumor Drugs by Regions
4.1 Brain Tumor Drugs Market Size by Regions (2017-2022)
4.2 Americas Brain Tumor Drugs Market Size Growth (2017-2022)
4.3 APAC Brain Tumor Drugs Market Size Growth (2017-2022)
4.4 Europe Brain Tumor Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Brain Tumor Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Brain Tumor Drugs Market Size by Country (2017-2022)
5.2 Americas Brain Tumor Drugs Market Size by Type (2017-2022)
5.3 Americas Brain Tumor Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brain Tumor Drugs Market Size by Region (2017-2022)
6.2 APAC Brain Tumor Drugs Market Size by Type (2017-2022)
6.3 APAC Brain Tumor Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Brain Tumor Drugs by Country (2017-2022)
7.2 Europe Brain Tumor Drugs Market Size by Type (2017-2022)
7.3 Europe Brain Tumor Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Brain Tumor Drugs by Region (2017-2022)
8.2 Middle East & Africa Brain Tumor Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Brain Tumor Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Brain Tumor Drugs Market Forecast
10.1 Global Brain Tumor Drugs Forecast by Regions (2023-2028)
10.1.1 Global Brain Tumor Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Brain Tumor Drugs Forecast
10.1.3 APAC Brain Tumor Drugs Forecast
10.1.4 Europe Brain Tumor Drugs Forecast
10.1.5 Middle East & Africa Brain Tumor Drugs Forecast
10.2 Americas Brain Tumor Drugs Forecast by Country (2023-2028)
10.2.1 United States Brain Tumor Drugs Market Forecast
10.2.2 Canada Brain Tumor Drugs Market Forecast
10.2.3 Mexico Brain Tumor Drugs Market Forecast
10.2.4 Brazil Brain Tumor Drugs Market Forecast
10.3 APAC Brain Tumor Drugs Forecast by Region (2023-2028)
10.3.1 China Brain Tumor Drugs Market Forecast
10.3.2 Japan Brain Tumor Drugs Market Forecast
10.3.3 Korea Brain Tumor Drugs Market Forecast
10.3.4 Southeast Asia Brain Tumor Drugs Market Forecast
10.3.5 India Brain Tumor Drugs Market Forecast
10.3.6 Australia Brain Tumor Drugs Market Forecast
10.4 Europe Brain Tumor Drugs Forecast by Country (2023-2028)
10.4.1 Germany Brain Tumor Drugs Market Forecast
10.4.2 France Brain Tumor Drugs Market Forecast
10.4.3 UK Brain Tumor Drugs Market Forecast
10.4.4 Italy Brain Tumor Drugs Market Forecast
10.4.5 Russia Brain Tumor Drugs Market Forecast
10.5 Middle East & Africa Brain Tumor Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Brain Tumor Drugs Market Forecast
10.5.2 South Africa Brain Tumor Drugs Market Forecast
10.5.3 Israel Brain Tumor Drugs Market Forecast
10.5.4 Turkey Brain Tumor Drugs Market Forecast
10.5.5 GCC Countries Brain Tumor Drugs Market Forecast
10.6 Global Brain Tumor Drugs Forecast by Type (2023-2028)
10.7 Global Brain Tumor Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Brain Tumor Drugs Product Offered
11.1.3 Pfizer Inc. Brain Tumor Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Information
11.2.2 Bristol-Myers Squibb Brain Tumor Drugs Product Offered
11.2.3 Bristol-Myers Squibb Brain Tumor Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bristol-Myers Squibb Main Business Overview
11.2.5 Bristol-Myers Squibb Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Brain Tumor Drugs Product Offered
11.3.3 AstraZeneca Brain Tumor Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Merck and Co. Inc.
11.4.1 Merck and Co. Inc. Company Information
11.4.2 Merck and Co. Inc. Brain Tumor Drugs Product Offered
11.4.3 Merck and Co. Inc. Brain Tumor Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck and Co. Inc. Main Business Overview
11.4.5 Merck and Co. Inc. Latest Developments
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Company Information
11.5.2 Johnson and Johnson Brain Tumor Drugs Product Offered
11.5.3 Johnson and Johnson Brain Tumor Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Johnson and Johnson Main Business Overview
11.5.5 Johnson and Johnson Latest Developments
12 Research Findings and Conclusion
Table 1. Brain Tumor Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Temozolomide
Table 3. Major Players of Carmustine
Table 4. Major Players of Cisplatin
Table 5. Major Players of Bevacizumab
Table 6. Major Players of Geftinib
Table 7. Major Players of Erlotinib
Table 8. Brain Tumor Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Brain Tumor Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Brain Tumor Drugs Market Size Market Share by Type (2017-2022)
Table 11. Brain Tumor Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Brain Tumor Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Brain Tumor Drugs Market Size Market Share by Application (2017-2022)
Table 14. Global Brain Tumor Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Brain Tumor Drugs Revenue Market Share by Player (2020-2022)
Table 16. Brain Tumor Drugs Key Players Head office and Products Offered
Table 17. Brain Tumor Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Brain Tumor Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Brain Tumor Drugs Market Size Market Share by Regions (2017-2022)
Table 22. Americas Brain Tumor Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Brain Tumor Drugs Market Size Market Share by Country (2017-2022)
Table 24. Americas Brain Tumor Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Brain Tumor Drugs Market Size Market Share by Type (2017-2022)
Table 26. Americas Brain Tumor Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Brain Tumor Drugs Market Size Market Share by Application (2017-2022)
Table 28. APAC Brain Tumor Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Brain Tumor Drugs Market Size Market Share by Region (2017-2022)
Table 30. APAC Brain Tumor Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Brain Tumor Drugs Market Size Market Share by Type (2017-2022)
Table 32. APAC Brain Tumor Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Brain Tumor Drugs Market Size Market Share by Application (2017-2022)
Table 34. Europe Brain Tumor Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Brain Tumor Drugs Market Size Market Share by Country (2017-2022)
Table 36. Europe Brain Tumor Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Brain Tumor Drugs Market Size Market Share by Type (2017-2022)
Table 38. Europe Brain Tumor Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Brain Tumor Drugs Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Brain Tumor Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Brain Tumor Drugs Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Brain Tumor Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Brain Tumor Drugs Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Brain Tumor Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Brain Tumor Drugs Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Brain Tumor Drugs
Table 47. Key Market Challenges & Risks of Brain Tumor Drugs
Table 48. Key Industry Trends of Brain Tumor Drugs
Table 49. Global Brain Tumor Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Brain Tumor Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Brain Tumor Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Brain Tumor Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Brain Tumor Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Brain Tumor Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 55. Pfizer Inc. Details, Company Type, Brain Tumor Drugs Area Served and Its Competitors
Table 56. Pfizer Inc. Brain Tumor Drugs Product Offered
Table 57. Pfizer Inc. Brain Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Pfizer Inc. Main Business
Table 59. Pfizer Inc. Latest Developments
Table 60. Bristol-Myers Squibb Details, Company Type, Brain Tumor Drugs Area Served and Its Competitors
Table 61. Bristol-Myers Squibb Brain Tumor Drugs Product Offered
Table 62. Bristol-Myers Squibb Main Business
Table 63. Bristol-Myers Squibb Brain Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Bristol-Myers Squibb Latest Developments
Table 65. AstraZeneca Details, Company Type, Brain Tumor Drugs Area Served and Its Competitors
Table 66. AstraZeneca Brain Tumor Drugs Product Offered
Table 67. AstraZeneca Main Business
Table 68. AstraZeneca Brain Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. AstraZeneca Latest Developments
Table 70. Merck and Co. Inc. Details, Company Type, Brain Tumor Drugs Area Served and Its Competitors
Table 71. Merck and Co. Inc. Brain Tumor Drugs Product Offered
Table 72. Merck and Co. Inc. Main Business
Table 73. Merck and Co. Inc. Brain Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. Merck and Co. Inc. Latest Developments
Table 75. Johnson and Johnson Details, Company Type, Brain Tumor Drugs Area Served and Its Competitors
Table 76. Johnson and Johnson Brain Tumor Drugs Product Offered
Table 77. Johnson and Johnson Main Business
Table 78. Johnson and Johnson Brain Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Johnson and Johnson Latest Developments
List of Figures
Figure 1. Brain Tumor Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Brain Tumor Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Brain Tumor Drugs Market Size Market Share by Type in 2021
Figure 7. Brain Tumor Drugs in Online
Figure 8. Global Brain Tumor Drugs Market: Online (2017-2022) & ($ Millions)
Figure 9. Brain Tumor Drugs in Offline
Figure 10. Global Brain Tumor Drugs Market: Offline (2017-2022) & ($ Millions)
Figure 11. Global Brain Tumor Drugs Market Size Market Share by Application in 2021
Figure 12. Global Brain Tumor Drugs Revenue Market Share by Player in 2021
Figure 13. Global Brain Tumor Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Brain Tumor Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Brain Tumor Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Brain Tumor Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Brain Tumor Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Brain Tumor Drugs Value Market Share by Country in 2021
Figure 19. Americas Brain Tumor Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Brain Tumor Drugs Market Size Market Share by Application in 2021
Figure 21. United States Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Brain Tumor Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Brain Tumor Drugs Market Size Market Share by Application in 2021
Figure 27. China Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Brain Tumor Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Brain Tumor Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Brain Tumor Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Brain Tumor Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Brain Tumor Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Brain Tumor Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Brain Tumor Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Brain Tumor Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
